Specifically, a higher BMI was associated with a statistically significant inverse risk of DKD (OR = 0.96, 95% CI: 0.92–0.99, p = 0.02), as was the use of ACE inhibitors or ARBs (OR = 0.50, 95% CI: 0.29–0.86, p = 0.01) (Table 2). The gene discussed is ACE; the disease is diabetic kidney disease.